Various studies reported the ability of Th17 to promote cancer growth; in particular, in CRC, Galon and collaborators found that a high infiltration of IL-17+ T cells was negatively correlated with patient’s prognosis (20), and Sharp et al. demonstrated that advanced stage colon cancer was associated with elevated Th17-associated cytokines (14). This evidence concerns the gene IL17A and cancer.